Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001129 · ClinicalTrials.gov registry record · NA
A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly
A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 1,248
- Enrollment target
NCT00001129 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,248 participants.
The verdict
NCT00001129, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 1,248 participants
- Enrollment target
Study Summary
The purpose of this study is to look at different ways to help patients follow their anti-HIV medication schedules. It is very important that HIV-positive patients take their anti-HIV medications correctly so they get the best possible benefit from them. Taking the drugs correctly, called "adherence," may keep HIV virus levels in the blood (viral load) low for a longer time. However, anti-HIV medication schedules are often complicated, and many patients have difficulty remembering to take their drugs at the correct time. This study will look at 2 different ways to teach patients about the importance of taking their medications correctly and to remind them when to take their medications.
Interventions
- DEVICE Electronic Medication Reminder System
- BEHAVIORAL Medication Manager
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,248 participants |
| Est. Completion | 2003-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001129
The ClinicalTrials.gov registry entry for NCT00001129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Medication Reminder System is the first listed.
NCT00001129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001129 about?
NCT00001129 is a clinical study titled "A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly". The purpose of this study is to look at different ways to help patients follow their anti-HIV medication schedules. It is very important that HIV-positive patients take their anti-HIV medications correctly so they get the best possible benefit from them. Taking the drugs correctly, called "adherenc...
What is the current status of trial NCT00001129?
This trial is currently completed. It is a NA study. The enrollment target is 1,248 participants. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00001129?
The interventions under investigation include: Electronic Medication Reminder System (DEVICE), Medication Manager (BEHAVIORAL).
Who is sponsoring clinical trial NCT00001129?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.